1. Özcan C, et al.Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):25-35. 2. Maddox TM, et al.Nonobstructive coronary artery disease...
QRISK2危险评估10年CVD风险》10% 的 40-74岁者 明确CVD患者 中国药物调脂治疗主要人群 • CVD已患患者 • 高血压人群(2010高血压血脂管理): – 合并≥1项靶器官损害,或合并≥3个血压升高以外的心 血管危险因素 – 高血压合并血压升高以外1～2个心血管危险因素者可 考虑 • 糖尿病人群(2013 指南): ...
参考文献 1.TsimikasS,et al. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-MediatedRisk of Cardiovascular Disease and Aortic Stenosis. J Am Coll Cardiol. 2018 Jan16;71(2):177-192. 3.WilsonDP, et al. Use of Lipoprotein(a) in clinical practice: A biomarker whose timehas come....
临床无ASCVD 或糖尿病, LDLC 70-189 mg/dL ,且10年ASCVD 风险7.5% 者,Pooled Cohort Risk Equations,ACC/AHA新调脂指南主要增加老年无CVD患者,QRISK2危险评估10年CVD风险10% 的40-74岁者 明确CVD患者,2014 NICE 指南:他汀干预人群,中国药物调脂治疗主要人群,CVD已患患者 高血压人群(2010高血压血脂管理): ...
those patients at greatest risk of recurrent ASCVD events that would benefit the greatest risk reduction from LDL-C lowering. In these patients, the guidelines give recommendations on the...
And following all possible recommendations may not be practical or appropriate as the number of chronic conditions increases, life expectancy shortens, and/or prognosis worsens, she added. Care Optimization During a recent ACC roundtable, clinicians and stakeholders from patient advocacy groups, health ...
The first intervention is passive with a display of the score on the EMR in the vital signs section and lasted for three months. The second intervention is collaborative where the nurses calculate the risk score and displayed it to the physician along with therapy recommendations. Electronic ...
The survey was based on 2016 and 2017 data from the Behavioral Risk Factor Surveillance System (BRFSS), a telephone-based questionnaire administered by the Centers for Disease Control and Prevention (CDC) to a random sample US adults in the community, the group notes. ...
If you look percentage wise, there are more women than men in terms of statin intolerance. As a clinician we are always treating one patient at a time, so you must plan. Paul, you mentioned going to 80 Bitorva [ezetimibe and atorvastatin], but if they don’t want to take 80, they...
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and ... Background: The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline recommends statin treatment bas...